RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

P Carmeliet^{1

2

3}, X Li¹, L Treps^{2

3}, L-C Conradi^{2

3}, S Loges^{4

5}

Affiliations

¹ State Key Laboratory of Ophthalmology (SKLO), Zhongshan Ophthalmic Center (ZOC), Sun Yat-Sen University, Guangzhou, P.R. China.
² Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), Leuven, Belgium.
³ Laboratory of Angiogenesis and Vascular Metabolism, VIB Center for Cancer Biology, Leuven, Belgium.
⁴ Department of Oncology and Hematology with Sections BMT and Pneumology.
⁵ Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 29360914
DOI: 10.1093/annonc/mdy028

Free article

Editorial

RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

P Carmeliet et al. Ann Oncol. 2018.

Free article

. 2018 Mar 1;29(3):527-529.

doi: 10.1093/annonc/mdy028.

Authors

P Carmeliet^{1

2

3}, X Li¹, L Treps^{2

3}, L-C Conradi^{2

3}, S Loges^{4

5}

Affiliations

¹ State Key Laboratory of Ophthalmology (SKLO), Zhongshan Ophthalmic Center (ZOC), Sun Yat-Sen University, Guangzhou, P.R. China.
² Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), Leuven, Belgium.
³ Laboratory of Angiogenesis and Vascular Metabolism, VIB Center for Cancer Biology, Leuven, Belgium.
⁴ Department of Oncology and Hematology with Sections BMT and Pneumology.
⁵ Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 29360914
DOI: 10.1093/annonc/mdy028

No abstract available

PubMed Disclaimer

Comment on

Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study.
Tabernero J, Hozak RR, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Prausová J, Muro K, Siegel RW, Konrad RJ, Ouyang H, Melemed SA, Ferry D, Nasroulah F, Van Cutsem E. Tabernero J, et al. Ann Oncol. 2018 Mar 1;29(3):602-609. doi: 10.1093/annonc/mdx767. Ann Oncol. 2018. PMID: 29228087 Free PMC article. Clinical Trial.

Cited by

[Influence of molecular markers on oncological surgery of colorectal cancer].
Nöpel-Dünnebacke S, Conradi LC, Reinacher-Schick A, Ghadimi M. Nöpel-Dünnebacke S, et al. Chirurg. 2021 Nov;92(11):986-995. doi: 10.1007/s00104-021-01486-7. Epub 2021 Aug 27. Chirurg. 2021. PMID: 34448902 Review. German.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

Affiliations

RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources